The Return of Investment for Preventive Healthcare Programmes

Résumé du livre

Workplace preventive health initiatives are growing in number and scope around the world, as employers increasingly realise the link between employee health and wellbeing and company's performance. The simple logic is that effective investment in health and wellbeing can save a company more than it spends on the interventions through reduced productivity losses due lower absenteeism and presenteeism, and lower healthcare spending overall. Multiple health promotion programmes are taking place in a number of pharmaceutical companies. In general, the goal of these programme are to improve the health and wellbeing of employees by: providing healthcare support; providing healthy lifestyle alternatives; developing a workplace culture that promotes and provides support for healthy living; and, considering the mental health needs of employees. GSK's Partnership for Prevention (P4P) aims to provide all GSK employees and their benefits-eligible dependants' access to preventive healthcare services. Some GSK employees work in countries where publicly funded preventive healthcare may be unavailable or limited, and this is where P4P bridges a gap. Some of the interventions, particularly those aimed at smoking cessation or lowering blood pressure and cholesterol, go beyond a simple substitution of necessary preventive healthcare services and aim to improve employee's wellbeing, as well as preventing possible future health complications. The report outlines the drivers of a successful workplace health promotion programmes, provides an overview of health and wellbeing interventions offered by pharmaceutical companies, and develops a framework to analyse the return on investment of such projects, applying it to GSK's P4P programme.